Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
What's Going On With BELLUS Health's Stock Today?
11:02am, Monday, 13'th Sep 2021
BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough. The stock is experiencing
BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data
08:36am, Monday, 13'th Sep 2021
BELLUS Health Inc (NASDAQ: BLU) has announced a positive interim analysis from Phase 2b SOOTHE trial of BLU-5937 for refractory chronic cough (RCC). BLU-5937, the Company's lead program, is a highl
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
07:45am, Monday, 13'th Sep 2021
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the tr
5 Penny Stocks To Watch For September With Upcoming Events
02:15pm, Monday, 30'th Aug 2021
These penny stocks could be in focus as we turn the page on a new month. The post 5 Penny Stocks To Watch For September With Upcoming Events appeared first on Penny Stocks to Buy, Picks, News and Info
Bellus Health - Betting Big On Chronic Cough Treatment
12:02am, Friday, 27'th Aug 2021
Bellus' lead drug candidate, BLU-5937, has the potential to capture significant market share if the drug attains commercialization. Bellus has adequate cash on its books, lasting until at least the du
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
04:30pm, Wednesday, 11'th Aug 2021
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the tr
New Strong Sell Stocks for May 25th
09:46am, Tuesday, 25'th May 2021
AJRD, BLU, GMBL, LITE, and PSXP have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2021
Los Angeles, California--(Newsfile Corp. - May 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("
New York, New York--(Newsfile Corp. - May 17, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September
New York, New York--(Newsfile Corp. - May 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BEL
Morganti & Co., P.L.C. Announces the Filing of a Securities Class Action on Behalf of Investors Who Acquired Bellus Health, Inc.
12:44pm, Saturday, 15'th May 2021
TORONTO--(BUSINESS WIRE)--Morganti & Co., A pro-investor law firm with licensed and experienced lawyers in Canada and the United States that represent investors announces the filing of a securities cl
BLU LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving BELLUS Health Inc.
04:49pm, Friday, 14'th May 2021
New York, New York--(Newsfile Corp. - May 14, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased BELLUS Health Inc.
New York, New York--(Newsfile Corp. - May 14, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t
New York, New York--(Newsfile Corp. - May 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between Septembe
Los Angeles, California--(Newsfile Corp. - May 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("
